The global rehabilitation robots market was valued at USD 1.7 billion in 2025. The market is projected to grow from USD 1.98 billion in 2026 to USD 6.72 billion by 2034, exhibiting a compound annual growth rate of 16.51% during the forecast period. Contrive Datum Insights presents this information in its report titled "Rehabilitation Robots Market Size, Share & Industry Analysis, By Type (Therapy Robots, Assistive Robots, Exoskeletons, Telerehabilitation Robots, Brain-Computer Interface Robots), Robotic structure (End-Effector Robots, Exoskeleton Robots, Hybrid Robots), Extremity (Upper Extremity, Lower Extremity, Full Body), Mobility mode (Stationary Systems, Overground Systems, Treadmill-Based Systems, Wearable Systems), Application (Stroke, Spinal Cord Injury, Traumatic Brain Injury, Cerebral Palsy, Multiple Sclerosis, Parkinson's Disease, Orthopedic and Sports Injuries, Others), Patient age group (Adult, Pediatric, Geriatric), Control technology (Electromyography (EMG)-Controlled, Brain-Computer Interface-Controlled, Force and Torque Sensor-Based, Joystick or Manual Control, AI-Adaptive Control), Actuation technology (Electric Actuators, Pneumatic Actuators, Hydraulic Actuators, Cable-Driven and Soft Actuators), Component (Hardware, Software, Services), End user (Hospitals, Rehabilitation Centers, Specialty Clinics, Home Care Settings, Research and Academic Institutes, Sports and Wellness Centers), Sales channel (Direct Sales, Distributors, Online Channels, Leasing and Rental), and Regional Forecast, 2026-2034".
Rehabilitation robots are powered, sensor-guided machines that help patients regain movement lost to stroke, spinal cord injury, brain injury, neurological disease or orthopaedic trauma. They take the form of fixed therapy stations, treadmill and overground gait trainers, wearable exoskeletons, assistive arms and remote or neural-interface systems, sold with the software and services that run them. Buyers are hospitals, rehabilitation centres, specialty clinics, research institutes, sports and wellness facilities and, increasingly, patients and carers using devices at home.
Rising stroke and neurological injury burden in ageing populations
Rising stroke and neurological injury burden in ageing populations is the largest single contributor to the market's growth over the forecast period, and the study rates its impact high. Against a market growing at 16.51% a year, the type lines exposed to it move fastest: Brain-Computer Interface Robots compounds at 26.9%, taking its share of revenue from 4% to 9% and its value from USD 0.068 billion to USD 0.605 billion.
On the upside, the study's bull case assumes reimbursement for powered exoskeletons spreads to several large national systems, component costs fall faster than expected, and home and remote rehabilitation devices reach routine use, lifting growth to 19% a year, which would take 2034 revenue to USD 8.123 billion against the USD 6.72 billion base case.
On the downside, hospital capital budgets stay tight, reimbursement stays limited to a few markets, and home devices fail to show clear clinical benefit, holding growth near 12.5% a year, which would hold 2034 revenue to USD 5.003 billion. Therapy Robots, which carries 38% of 2025 revenue, already grows at only 13.9% against the market's 16.51%, so the largest part of the base is also its slowest.
The Competitive Split Runs by Type
The type axis, not the regional one, is what divides the field. Therapy Robots is the volume position, 38% of 2025 revenue at USD 0.646 billion, holding 31% through 2034, and it is defended by scale. Brain-Computer Interface Robots is the growth position at 26.9%, and it is open. Strength in one does not carry into the other.
Further Report Findings
| Segment | Led 2025 by | Share & value | Fastest-growing |
|---|---|---|---|
| Robotic structure | Exoskeleton Robots | 45% · USD 0.765 billion | Hybrid Robots 18.1% |
| Extremity | Lower Extremity | 46% · USD 0.782 billion | Full Body 20% |
| Mobility mode | Stationary Systems | 28% · USD 0.476 billion | Wearable Systems 20.2% |
| Application | Stroke | 38% · USD 0.646 billion | Others 20.3% |
| Patient age group | Adult | 55% · USD 0.935 billion | Pediatric 19.4% |
| Control technology | Force and Torque Sensor-Based | 30% · USD 0.51 billion | Brain-Computer Interface-Controlled 25.8% |
| Actuation technology | Electric Actuators | 70% · USD 1.19 billion | Cable-Driven and Soft Actuators 24.4% |
| Component | Hardware | 72% · USD 1.224 billion | Software 21.1% |
| End user | Hospitals | 46% · USD 0.782 billion | Home Care Settings 30.4% |
| Sales channel | Direct Sales | 62% · USD 1.054 billion | Online Channels 25.8% |
- Based on regional analysis, North America led the global rehabilitation robots market in 2025 with 38% of global revenue at USD 0.646 billion, reaching USD 2.15 billion by 2034.
- Asia Pacific takes a rising share of global revenue over the forecast period, from 24% in 2025 to 33% in 2034, with revenue growing from USD 0.408 billion to USD 2.218 billion.
- Latin America stays the smallest contributor across the period: 4% of revenue in 2025 and 4% in 2034.
- Therapy Robots was the leading type line in 2025, taking 38% of revenue at USD 0.646 billion.
- Brain-Computer Interface Robots is projected to grow at 26.9% over the forecast period, the fastest of any type line.
- The United States is the largest single country market at USD 0.568 billion in 2025, 33.4% of global revenue.
The study covers eleven axes, by type, and by robotic structure, extremity, mobility mode, application, patient age group, control technology, actuation technology, component, end user and sales channel, reporting revenue and a growth rate for every line in every year from 2020 to 2034, with bear, base and bull scenarios on the headline total at USD 5.003 billion and USD 8.123 billion by 2034. Country-level detail is given for all five regions, together with the competitive landscape and the research methodology. Delivered as a PDF; request a free sample to review it.